Demand for bone metabolism tests will increase through 2036, with bone marker tests at 27.5% of the test types segment in 2026, driven by increasing clinical adoption and compliance requirements. The market was valued at USD 3.10 billion in 2025 and is expected to be worth USD 6.87 billion by 2036.